par 545 (Ranitidine 300 mg)

Pill imprint par 545 has been identified as Ranitidine hydrochloride 300 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; zollinger-ellison syndrome; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for par 545

Ranitidine hydrochloride 300 mg par 545  Front
Ranitidine hydrochloride 300 mg par 545  Back
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride 300 mg par 545
Ranitidine hydrochloride
Imprint:
par 545
Strength:
300 mg
Color:
Yellow
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Par Pharmaceutical Inc.
National Drug Code (NDC):
49884-0545
Inactive Ingredients:
FD&C Yellow No. 6
lactose monohydrate
magnesium stearate
microcrystalline cellulose
pregelatinized corn starch
titanium dioxide
triethyl citrate
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
62584-0253 Amerisource Health Services
54868-4350 Physicians Total Care Inc (repackager)
49999-0428 Lake Erie Medical and Surgical Supply (repackager)
68115-0404 Dispensexpress Inc (repackager)
63874-0428 Altura Pharmaceuticals Inc (repackager)
66267-0452 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)